Department of Defense (DoD) Breast Cancer Research Program Synergistic Idea Award

The summary for the Department of Defense (DoD) Breast Cancer Research Program Synergistic Idea Award grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.

Department of Defense (DoD) Breast Cancer Research Program Synergistic Idea Award: The Breast Cancer Research Program (BCRP) Synergistic Idea Award supports collaborations between two independent, faculty-level (or equivalent) investigators who address an innovative, high-risk, potentially high-reward breast cancer research question from synergistic and complementary perspectives.The Synergistic Idea Award is designed to promote new ideas and new collaborations. Proposals are not required to include preliminary data, but a rationale for the work must be provided. Proposals should have a high probability of revealing new avenues of investigation, if successful. The Synergistic Idea Award requires the submission of a single proposal that addresses a critical issue in breast cancer research. The proposal may be structured as either two separate but complementary and highly synergistic objectives, or as a balanced, synergistic collaboration integrated into a single project. Proposals must clearly define the synergistic components that will enable or greatly accelerate the evaluation of a single innovative hypothesis. The BCRP seeks proposals from all areas of laboratory, preclinical, behavioral, and epidemiological research. Multi-institutional and/or multidisciplinary proposals are encouraged but not required. Collaborators not from distinct disciplines must clearly explain why the proposed research is synergistic. Major disciplines include, but are not limited to: biological sciences (including both basic and clinical sciences); chemical sciences; social and behavioral sciences; engineering, physical, and mathematical sciences; and public health research. Innovation: Innovation is a significant feature of this award. Research deemed innovative may introduce a new paradigm, challenge current paradigms, look at existing problems from new perspectives, or exhibit other uniquely creative qualities. Examples of research that is not innovative and will not be considered for funding under this award mechanism include: . Investigating the next logical step as an extension of previous work or incremental advancement of published data. . Exploring a hypothesis in a different cell line or in a new population. . Using a published series of in vitro assays to further characterize a model system. . Incorporating known biomarkers into in vitro or clinical models of breast cancer. Synergy: Synergy is another significant feature of this award. Research combinations that have the highest synergy will be those that significantly advance a project beyond what would be possible through separate efforts. Contributions to the synergy of this mechanism are expected to be balanced between the two investigators unless otherwise justified. It should be clear that both investigators have an equal level of intellectual input into the proposed project. This award mechanism is designed to support completely new ideas, not ideas that are extensions of existing collaborative efforts. New collaborations are strongly encouraged but not required. If the investigators have a history of collaboration, then they must clearly demonstrate how the proposed research is a new synergistic idea. Examples of a collaboration that is not synergistic and will not be considered for funding under this award mechanism include: . Tissue samples/cell lines/expression vectors supplied by one collaborator and molecular studies completed by the other collaborator.. Laboratory investigations or statistical analyses provided as a service function or core support.Impact: This award mechanism supports high-risk, potentially high-reward research. Therefore, the evaluation of the impact of the proposed research will be based on the probability of significantly advancing the understanding, prevention, detection, diagnosis, and/or treatment of breast cancer, or the quality of life for patients. The investigators must clearly and explicitly articulate the potential impact the project may have on the field of breast cancer research and/or patient care.